Journal of Medical Economics

Title Publication Date Language Citations
Atrial fibrillation and anticoagulation management: a wake-up call to practitioners, patients, and policymakers2013/08/23English
Author response2014/06/11English
Regression analysis of indicating multiple incremental cost-effectiveness ratios for non-small cell lung cancer treatment2014/05/29English
Economic outcomes with prasugrel versus clopidogrel in acute coronary syndrome patients: observations from prasugrel users and matched clopidogrel users2015/08/20English
Re: Cost-effectiveness of continuous subcutaneous apomorphine in the treatment of Parkinson’s Disease in the UK and Germany2015/07/21English
RETRACTED ARTICLE: Hospitalization-related costs associated with oral agents targeting the prostacyclin pathway for pulmonary arterial hypertension2023/10/31English
Characterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United States2024/03/11English
The economic burden of systemic lupus erythematosus in Mexico2024/03/06English
Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation2024/02/02English
Evaluation of four disease management programs: evidence from blue cross blue shield of Louisiana2020/02/13English
An economic evaluation attached to a single-centre, parallel group, unmasked, randomized controlled trial of a 3-day intensive social cognitive treatment (can do treatment) in patients with relapsing remitting multiple sclerosis and low disability2019/05/14English
Reply: RE: a cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy, and Spain2019/02/13English
RE: A cost-effectiveness modeling evaluation comparing a biosimilar follitropin alfa preparation with its reference product for live birth outcome in Germany, Italy, and Spain2019/02/11English
Reply: Re: Wu JJ, Hansen JB, Patel DS, et al. Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adjusted indirect comparative analysis. J Med Econ. 2020;23(6):641–6492020/11/06English
Re: Wu JJ, Hansen JB, Patel DS, et al. Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adjusted indirect comparative analysis. J Med Econ. 2020;23(6):641–6492020/11/06English
Retrospective database analysis of healthcare resource utilization and costs in patients who develop post-transplant lymphoproliferative disease within the first year following allogeneic hematopoietic stem cell transplants2020/07/22English
Cost-effectiveness of 4 mg dibotermin alfa/absorbable collagen sponge versus iliac crest bone graft for lumbar degenerative disc disease in the United Kingdom2021/12/27English
Re: Harris L, Graham S, MacLachlan S, et al. Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England. J Med Econ. 2019;22(7):691–6972021/01/01English
Clinical and economic benefits of hospital drug management rationalization2022/06/16English
Ambulatory and hospital care of glaucoma in Spain and associated medical costs2022/06/09English
Economic and clinical impact of a novel, light-based, at-home antiviral treatment on mild-to-moderate COVID-192022/04/09English
The tyranny of the SW quadrant2021/01/01English
A discrete choice experiment investigating HIV testing preferences in South Africa2022/04/06English
Response to: Demarteau N, Standaert B. Modelling the economic value of cross- and sustained-protection in vaccines against cervical cancer. J Med Econ 2010;13:324–382011/01/01English
Inverse probability weighting to control for censoring in a post hoc analysis of quality-adjusted survival data from a clinical trial of temsirolimus for renal cell carcinoma2011/01/01English
Letter to the Editor2014/04/09English
Assessment of income growth in patients with rheumatoid arthritis treated with anti-tumor necrosis factor therapy2014/10/15English
Exploratory analysis of psychiatric-related utilization and costs associated with paliperidone ER compared with other oral atypical antipsychotics using pharmacy claims from an administrative database2010/10/06English
Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram: a 6-month retrospective study2010/09/29English
Burden of illness among patients at high risk versus low risk for major cardiovascular events2010/07/21English